A 10-year-old child presents to a pediatric emergency department with an acute asthma exacerbation of moderate severity and is prescribed continuous albuterol therapy. A colleague asks whether early BPAP should be expected to reduce the duration of continuous albuterol therapy based on a recent randomized trial.